stockrowCelldex Therapeutics, Inc.
CLDX Healthcare Biotechnology
Celldex Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 million, down 78.0% from fiscal 2024.
- Revenue
- −96.8%
- EPS
- −10.6%
- Free cash flow
- −35.5%
Quarter to June 2026, against a year earlier
Follow CLDX
Alert me
Celldex Therapeutics, Inc. (CLDX) Operating margin
Celldex Therapeutics, Inc.'s operating margin over the twelve months to 30 June 2026 was −36,733.8%, down 18134.0 percentage points from fiscal 2025 (−18,599.8%). Over the past ten years it has ranged from −18,599.8% (fiscal 2025) to −854.1% (fiscal 2020) — the current reading is the lowest in ten years. That is below the Biotechnology industry median of 0.00% and below the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | −18,599.8% | (15,820.92) |
| FY2024 | −2,778.9% | (533.62) |
| FY2023 | −2,245.3% | 2,643.74 |
| FY2022 | −4,889.0% | (3,357.23) |
| FY2021 | −1,531.8% | (677.72) |
| FY2020 | −854.1% | 686.13 |
| FY2019 | −1,540.2% | 99.94 |
| FY2018 | −1,640.1% | (686.45) |
| FY2017 | −953.7% | 1,005.00 |
| FY2016 | −1,958.7% | 405.21 |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Jun 2026 | −366,468.2% | 196,431.82 |
| Mar 2026 | −562,900.0% | (490,271.67) |
| Dec 2025 | −72,628.3% | (72,628.33) |
| Sep 2025 | 0.00% | 8,747.53 |
| 42 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| ADMA ADMA Biologics Inc compare | 46.5% |
| AUPH Aurinia Pharmaceuticals Inc compare | 44.8% |
| VCEL Vericel Corporation compare | 8.32% |
| IMNM Immunome, Inc. compare | 0.00% |
| VERA Vera Therapeutics, Inc. compare | 0.00% |
| BHVN Biohaven Ltd. compare | 0.00% |
| PHVS Pharvaris N.V. compare | 0.00% |
| PVLA Palvella Therapeutics, Inc. compare | 0.00% |
| CLDX Celldex Therapeutics, Inc. | −36,733.8% |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on CLDX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement